Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
ProbucolThis study is a multicenter, double-blind, placebo-controlled, randomized clinical trial that aims to evaluate the efficacy of probucol on the reduction of the risk of recurrent stroke in patients with symptomatic intracranial or extracranial arterial stenosis. Accident vasculaire cérébral Phase 3 Traitement symptomatique China À vérifier
ProbucolThis study is a multicenter, double-blind, placebo-controlled, randomized clinical trial that aims to evaluate the efficacy of probucol on the reduction of the risk of recurrent stroke in patients with symptomatic intracranial or extracranial arterial stenosis. Accident vasculaire cérébral Phase 3 Traitement symptomatique China À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Probucol Accident vasculaire cérébral Phase 3 NCT06225752 Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis RECRUITING

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.